IPO

Krishna Institute of Medical Sciences (KIMS) IPO

Mainboard

Hospital & Healthcare Services

Listed On: Jun 28, 2021 at ₹ 1009(NSE)

₹ 14850 /18 Shares

Check Allotment

16 Jun, 2021

Open Date

18 Jun, 2021

Close Date

23 Jun, 2021

Allotment Date

28 Jun, 2021

Listing Date
Price Summary

Last Closing

637.90 (-22.68%)

52 Week High

798.40

52 Week Low

474.05

Last Update

19-Dec-2025 3:30 PM
IPO Issue Details
  • Issue Price ₹815-825 per equity share
  • Face Value ₹10 Per Equity Share 
  • Issue Price N/A Eq Shares of ₹10 (aggregating up to ₹2,143.74 Cr)

    #Fresh Issue: 2,424,242 Eq Shares of ₹10 (aggregating up to ₹200.00 Cr)

    Offer for Sale: 23,560,538 Eq Shares of ₹10 (aggregating up to ₹1,943.74 Cr)
  • Listing at BSE, NSE
  • List Price 1009(NSE)
  • Listing Date 2021-06-28
  • Lead Manager Axis Capital Limited, Credit Suisse Securities (India) Private Limited, IIFL Holdings Limited, Kotak Mahindra Capital Company Limited
  • Registrar Link Intime India Private Ltd
IPO Details
  • Retail Portion 10%
IPO Documents
DRHP
RHP
IPO Details


The IPO of is priced at ₹815-825 per equity share, which has a face value of ₹10 Per Equity Share  each, IPO bidding starts from Jun 16, 2021 and ends on Jun 18, 2021. The allotment for IPO will be finalized on Jun 23, 2021. IPO will be listed on BSE, NSE, with a tentative listing date fixed as Jun 28, 2021. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.

The book-running lead manager for the IPO is/are Axis Capital Limited, Credit Suisse Securities (India) Private Limited, IIFL Holdings Limited, Kotak Mahindra Capital Company Limited.


The IPO sets its price band at 815-825 for each share. A single application for Krishna Institute of Medical Sciences (KIMS) IPO must contain at least 18 shares.

Read More
IPO Subscription Analysis And Details
Retail
2.90x
QIB
5.27x
NII
1.89x
Total
3.86x
As on QIB NII Retail Employee Total
Shares Offered / Reserved 77,22,708 38,61,353 25,74,235 2,54,777 1,44,13,073
Day 1 16-06-20 05:00 PM
0.14 x 0.03 1.00 x 0.27 x 0.27 x
Day 2 17-06-20 05:00 PM
0.32 x 0.09 1.95 x 0.66 x 0.56 x
Day 3 18-06-20 05:00 PM
5.27 x 1.89 2.90 x 1.06 x 3.86 x
Total No of Applications
2.23
Subscription on the basis of Applications
319264
Valuations
Earnings Per Share (EPS) ₹26.87-
P/E Ratio 26
RoNW 23.30%
Net Asset Value (NAV) - As on 31.03.21 ₹115.36
Company Financials
In Crs.
In Cr.
31-Mar-21 31-Mar-20 31-Mar-19
Assets 1,436.15 1,195.89 1,119.71
Revenue 1,340.10 1,128.72 923.86
Profit After Tax 205.47 115.07 (48.80)
About Company

Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities. The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

As of March 31, 2021, it operates through 9 multi-speciality hospitals under the brand name of "KIMS Hospitals" with an aggregate bed capacity of 3,064 under the "KIMS Hospitals" brand, with an aggregate bed capacity of 3,064 including over 2,500 operational beds.

Read More
- Promoter(s)

Dr. Bhaskara Rao Bollineni

Rajyasri Bollineni

Dr. Abhinay Bollineni

Adwik Bollineni

Bollineni Ramanaiah Memorial Hospitals Private Limited

Pre Issue Share Holding : 46.81%

Post Issue Share Holding : 38.84%

IPO - Issue Objectives
1

To make repayment/prepapyment of borrowings availaled by the firm and subsidiaries i.e. KHKPL, SIMSPL, and KHEPL.

2

To meet general corporate purposes.

IPO - Anchor Investors

KIMS Hospitals mops up Rs 956 crore from 43 anchor investors ahead of IPO

Domestic investors invested in the company through anchor book included HDFC Trustee, Axis Mutual Fund, ICICI Prudential, Nippon Life India, IDFC MF, UTI MF, Mirae MF, and HDFC Life Insurance Company

Marquee investors participated in the anchor book were Nomura Funds, Stock Mother Fund, Segantii India Mauritius, Goldman Sachs, Zaaba Pan Asia Master Fund, Integrated Core Strategies, Moon Capital, Ghisallo Master Fund, and Societe Generale.